Zai Lab Limited (ZLAB) Stock Jumps 6.8%: Will It Continue to Soar?

By Zacks Equity Research | July 23, 2025, 9:57 AM

Vertex Pharmaceuticals, Inc

Zai Lab Limited ADR

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Zai Lab Limited Unsponsored ADR (ZLAB): Free Stock Analysis Report

Vertex Pharmaceuticals Incorporated (VRTX): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Vertex Pharmaceuticals, Inc

Zai Lab Limited ADR

Latest News

4 hours	Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3 VRTX Business Wire
11 hours	Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock VRTX Zacks
19 hours	Vertex Pharmaceuticals Stock: Is Wall Street Bullish or Bearish? VRTX Barchart
Feb-16	Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders VRTX Zacks
Feb-15	Entrada Therapeutics Teases Data-Rich 2026 With DMD and DM1 Catalysts at Guggenheim Summit VRTX MarketBeat
Feb-14	Crispr Therapeutics price target raised to $74 from $62 at Evercore ISI VRTX TipRanks
Feb-13	Small Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday? VRTX +5.69% Benzinga
Feb-13	CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens VRTX +5.69% Benzinga
Feb-13	VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales VRTX +5.69% Zacks
Feb-13	Moderna Q4 Loss Narrower-Than-Expected, Sales Beat Estimates VRTX +5.69% Zacks
Feb-13	CRSP Posts Wider-Than-Expected Loss in Q4, Sales Miss Estimates VRTX +5.69% Zacks
Feb-13	Vertex Pharma (VRTX) Renal Pipeline Seen as Major Growth Driver by Barclays VRTX +5.69% Insider Monkey
Feb-13	Stock Market Today: Dow Slips After CPI Inflation Surprise; DraftKings Plunges On Earnings (Live Coverage) VRTX +5.69% Investor's Business Daily
Feb-13	VRTX Q4 Deep Dive: Diversification Beyond Cystic Fibrosis Sets Stage for Next Growth Phase VRTX +5.69% StockStory
Feb-13	Vertex Pharmaceuticals Inc (VRTX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... VRTX +5.69% GuruFocus.com

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.